Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDAP Edap Tms	$1.78 +2.0%	$1.84	$1.26 ▼ $6.01	$66.37M	0.13	98,316 shs	21,363 shs
NYXH Nyxoah	$7.85 +1.3%	$6.74	$5.55 ▼ $11.87	$267.37M	1.56	74,793 shs	240,638 shs
SNWV SANUWAVE Health	$27.62 -1.3%	$31.00	$5.17 ▼ $39.50	$236.32M	1.25	31,796 shs	24,826 shs
STIM Neuronetics	$3.85 -3.0%	$4.08	$0.52 ▼ $5.92	$261.31M	1.92	752,555 shs	395,955 shs

Free Today: Your Guide to Smarter Options Trades

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDAP Edap Tms	+1.98%	+2.01%	-18.58%	-31.99%	-69.50%
NYXH Nyxoah	+1.29%	-2.48%	+30.62%	-22.39%	-8.19%
SNWV SANUWAVE Health	-1.25%	-11.47%	+0.80%	+2,761,999,900.00%	+2,761,999,900.00%
STIM Neuronetics	-3.02%	-3.99%	-13.48%	-10.05%	+85.10%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDAP Edap Tms	2.8849 of 5 stars	3.2	5.0	0.0	0.0	2.8	1.7	0.6
NYXH Nyxoah	2.6392 of 5 stars	3.5	4.0	0.0	0.0	2.7	0.8	0.6
SNWV SANUWAVE Health	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	2.8006 of 5 stars	3.3	4.0	0.0	0.0	3.0	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDAP Edap Tms	2.33	Hold	$8.50	378.87% Upside
NYXH Nyxoah	3.00	Buy	$14.50	84.71% Upside
SNWV SANUWAVE Health	0.00	N/A	N/A	N/A
STIM Neuronetics	2.67	Moderate Buy	$5.50	42.86% Upside

Current Analyst Ratings Breakdown

Latest EDAP, NYXH, STIM, and SNWV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/15/2025	EDAP Edap Tms	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
4/21/2025	NYXH Nyxoah	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $14.00
4/8/2025	NYXH Nyxoah	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $15.00
4/4/2025	EDAP Edap Tms	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$8.00 ➝ $2.00
3/28/2025	EDAP Edap Tms	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$5.00 ➝ $4.50
3/28/2025	EDAP Edap Tms	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00 ➝ $19.00
3/26/2025	NYXH Nyxoah	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $15.00
3/14/2025	NYXH Nyxoah	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$16.00 ➝ $15.00
3/5/2025	STIM Neuronetics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$5.00 ➝ $8.00

(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDAP Edap Tms	$62.77M	1.06	N/A	N/A	$1.66 per share	1.07
NYXH Nyxoah	$4.36M	61.27	N/A	N/A	N/A	∞
SNWV SANUWAVE Health	$36.19M	6.53	N/A	N/A	N/A	∞
STIM Neuronetics	$89.45M	2.83	N/A	N/A	$1.18 per share	3.26

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDAP Edap Tms	-$22.92M	-$0.62	N/A	N/A	N/A	-34.92%	-44.21%	-25.88%	N/A
NYXH Nyxoah	-$46.77M	-$2.13	N/A	N/A	N/A	-1,043.93%	-51.68%	-40.11%	8/5/2025 (Estimated)
SNWV SANUWAVE Health	N/A	-$4.56	N/A	∞	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	-$30.19M	-$1.31	N/A	N/A	N/A	-50.09%	-141.24%	-32.77%	8/11/2025 (Estimated)

Latest EDAP, NYXH, STIM, and SNWV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q1 2025	EDAP Edap Tms	-$0.16	-$0.20	-$0.04	-$0.20	$16.56 million	$16.37 million
5/14/2025	Q1 2025	NYXH Nyxoah	-$0.49	-$0.63	-$0.14	-$0.63	$1.64 million	$1.12 million
5/9/2025	Q1 2025	SNWV SANUWAVE Health	N/A	-$0.66	N/A	-$0.66	N/A	$9.34 million
5/6/2025	Q1 2025	STIM Neuronetics	-$0.13	-$0.21	-$0.08	-$0.21	$29.07 million	$31.98 million
3/27/2025	Q4 2024	EDAP Edap Tms	-$0.11	-$0.05	+$0.06	-$0.05	$20.83 million	$22.69 million
3/13/2025	Q4 2024	NYXH Nyxoah	-$0.46	-$0.49	-$0.03	-$0.49	$2.02 million	$1.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDAP Edap Tms	N/A	N/A	N/A	N/A	N/A
NYXH Nyxoah	N/A	N/A	N/A	N/A	N/A
SNWV SANUWAVE Health	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDAP Edap Tms	0.08	2.18	1.46
NYXH Nyxoah	0.21	5.28	4.95
SNWV SANUWAVE Health	N/A	N/A	N/A
STIM Neuronetics	4.90	3.16	2.87

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDAP Edap Tms	62.74%
NYXH Nyxoah	N/A
SNWV SANUWAVE Health	42.53%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
EDAP Edap Tms	0.23%
NYXH Nyxoah	17.11%
SNWV SANUWAVE Health	36.60%
STIM Neuronetics	8.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDAP Edap Tms	230	37.39 million	37.02 million	Optionable
NYXH Nyxoah	110	34.06 million	28.23 million	Not Optionable
SNWV SANUWAVE Health	40	8.56 million	N/A	N/A
STIM Neuronetics	180	65.82 million	27.37 million	Optionable

EDAP, NYXH, STIM, and SNWV Headlines

Recent News About These Companies

Neuronetics, Inc. (NASDAQ:STIM) EVP Sells $826,074.20 in Stock

May 15, 2025 | insidertrades.com

Balyasny Asset Management L.P. Grows Position in Neuronetics, Inc. (NASDAQ:STIM)

May 15, 2025 | marketbeat.com

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

May 14, 2025 | tmcnet.com

Q2 EPS Estimates for Neuronetics Reduced by William Blair

May 11, 2025 | marketbeat.com

Neuronetics Announces Inducement Awards for New Team Members

May 10, 2025 | msn.com

Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83

May 9, 2025 | finance.yahoo.com

Neuronetics (NASDAQ:STIM) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS

May 8, 2025 | marketbeat.com

Renaissance Technologies LLC Has $255,000 Position in Neuronetics, Inc. (NASDAQ:STIM)

May 8, 2025 | marketbeat.com

Earnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22%

May 7, 2025 | investing.com

Neuronetics Reports 84% Revenue Growth in Q1 2025 Driven by Greenbrook Acquisition

May 7, 2025 | nasdaq.com

Neuronetics Reports 84% Revenue Growth in Q1 2025 Driven by Greenbrook Acquisition

May 7, 2025 | nasdaq.com

Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges

May 7, 2025 | finance.yahoo.com

Neuronetics, Inc. (STIM) Q1 2025 Earnings Call Transcript

May 6, 2025 | seekingalpha.com

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

May 6, 2025 | zacks.com

Neuronetics Reports First Quarter 2025 Financial and Operating Results

May 6, 2025 | globenewswire.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 5, 2025 | globenewswire.com

Neuronetics (STIM) to Release Quarterly Earnings on Tuesday

May 1, 2025 | marketbeat.com

Why Neuronetics, Inc. (STIM) is Surging in 2025

April 30, 2025 | msn.com

Neuronetics to Announce Q1 2025 Results and Host Live Conference Call on May 6

April 24, 2025 | msn.com

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

April 22, 2025 | tmcnet.com

Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression

April 2, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
By Thomas Hughes | May 27, 2025
View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long
By Sam Quirke | May 13, 2025
View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long
Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook
By Leo Miller | May 27, 2025
View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook
Workday Stock Price Implosion: An Automatic Buy for AI Investors
By Thomas Hughes | May 26, 2025
View Workday Stock Price Implosion: An Automatic Buy for AI Investors
Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan
By Jeffrey Neal Johnson | May 3, 2025
View Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan

EDAP, NYXH, STIM, and SNWV Company Descriptions

Edap Tms NASDAQ:EDAP

$1.77 +0.03 (+1.69%)

As of 05/28/2025 04:00 PM Eastern

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Nyxoah NASDAQ:NYXH

$7.85 +0.10 (+1.29%)

Closing price 05/28/2025 04:00 PM Eastern

Extended Trading

$7.86 +0.01 (+0.06%)

As of 05/28/2025 06:01 PM Eastern

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

SANUWAVE Health NASDAQ:SNWV

$27.62 -0.35 (-1.25%)

As of 05/28/2025 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Neuronetics NASDAQ:STIM

$3.85 -0.12 (-3.02%)

Closing price 05/28/2025 04:00 PM Eastern

Extended Trading

$3.83 -0.02 (-0.55%)

As of 05/28/2025 07:43 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time